Loading...
Regen BioPharma, Inc.
RGBP•PNK
HealthcareBiotechnology
$0.06
$0.01(31.80%)
Regen BioPharma, Inc. (RGBP) Financial Performance & Statements
Review Regen BioPharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
39.12%
↑ 39.12%
Net Income Growth
-184.73%
↓ 184.73%
Operating Cash Flow Growth
-298.55%
↓ 298.55%
Operating Margin
-155.54%
↓ 155.54%
Gross Margin
42.66%
↑ 42.66%
Net Profit Margin
-408.05%
↓ 408.05%
ROE
18.27%
↑ 18.27%
ROIC
6.57%
↑ 6.57%
Regen BioPharma, Inc. (RGBP) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Regen BioPharma, Inc. stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $236560.00 | $236560.00 | $235517.00 | $171194.00 |
| Cost of Revenue | $77215.00 | $0.00 | $50000.00 | $25000.00 |
| Gross Profit | $159345.00 | $236560.00 | $185517.00 | $146194.00 |
| Gross Profit Ratio | $0.67 | $1.00 | $0.79 | $0.85 |
| R&D Expenses | $153685.00 | $212297.00 | $275388.00 | $36704.00 |
| SG&A Expenses | $423849.00 | $711212.00 | $299734.00 | $335260.00 |
| Operating Expenses | $577534.00 | $923510.00 | $575122.00 | $371964.00 |
| Total Costs & Expenses | $654749.00 | $923510.00 | $575122.00 | $371964.00 |
| Interest Income | $0.00 | $0.00 | $455.00 | $230.00 |
| Interest Expense | $0.00 | $309448.00 | $209787.00 | $367028.00 |
| Depreciation & Amortization | $521508.00 | $1.90M | $339605.00 | $200770.00 |
| EBITDA | -$418189.00 | $1.22M | $2.99M | -$6.40M |
| EBITDA Ratio | -$1.77 | $5.14 | -$1.37 | -$1.17 |
| Operating Income | -$418189.00 | -$686950.00 | -$339605.00 | -$200771.00 |
| Operating Income Ratio | -$1.77 | -$2.90 | -$1.44 | -$1.17 |
| Other Income/Expenses (Net) | -$449063.00 | $1.84M | $2.78M | -$6.56M |
| Income Before Tax | -$867252.00 | $1.16M | $2.44M | -$6.77M |
| Income Before Tax Ratio | -$3.67 | $4.89 | $10.38 | -$39.52 |
| Income Tax Expense | $0.00 | $0.00 | -$3.05M | $366798.00 |
| Net Income | -$867252.00 | $1.02M | $5.49M | -$7.13M |
| Net Income Ratio | -$3.67 | $4.33 | $23.31 | -$41.66 |
| EPS | -$0.21 | $0.29 | $1.75 | -$3.55 |
| Diluted EPS | -$0.21 | $0.29 | $1.75 | -$3.55 |
| Weighted Avg Shares Outstanding | $8.91M | $3.54M | $3.14M | $2.008M |
| Weighted Avg Shares Outstanding (Diluted) | $8.91M | $3.54M | $3.14M | $2.008M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan